- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Skyepharma Share News (SKP)
Share News for Skyepharma (SKP)
| Share Price: 49.125 | Bid: 48.25 | Ask: 50.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
BRIEF-SkyePharma in 18.4 mln stg placing and open offer
Mon, 1st Sep 2008 18:54
LONDON, Sept 1 (Reuters) - SkyePharma Plc:
* Announces proposals for renegotiated
* A related fully underwritten Placing and Open Offer of 1,401,780,736 new shares to raise 18.4 million pounds (net of expenses), and a share capital reorganisation
* The new ordinary shares have been placed by Credit Suisse and Piper Jaffray, the company's brokers, with a range of existing and new institutional and strategic investors ((London Equities Newsroom; +44 20 7542 7717))
tf.TFN-Europe_newsdesk@thomson.com
ak
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
LONDON, Sept 1 (Reuters) - SkyePharma Plc
* Announces proposals for renegotiated
terms for the 2024 and 2025 convertible bonds, extending put dates to 2013 and 2014 respectively and resetting the conversion price
* A related fully underwritten Placing and Open Offer of 1,401,780,736 new shares to raise 18.4 million pounds (net of expenses), and a share capital reorganisation
* The new ordinary shares have been placed by Credit Suisse and Piper Jaffray, the company's brokers, with a range of existing and new institutional and strategic investors ((London Equities Newsroom; +44 20 7542 7717))
tf.TFN-Europe_newsdesk@thomson.com
ak
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
BRIEF-Skyepharma - Revenues show strong growth
LONDON, Oct 27 (Reuters) - SkyePharma PLC: * Revenues since July 1, continue to show significant growth compared with the 2007 run r[27 Oct '08]
BRIEF-SkyePharma successfully completes Flutiform U.S. trials
LONDON, Oct 23 (Reuters) - SkyePharma PLC: * Successful completion of Flutiform U.S. clinical trial programme * Final U.S. Phase III e[23 Oct '08]
Skyepharma says bond proposals, placing, open offer seen finalised on Sept. 25
LONDON (Thomson Financial) - Specialist British drug delivery company Skyepharma Plc. said it expects its bond proposals, placing and open offer[23 Sep '08]
STOCKS NEWS EUROPE-UK small cap index stay flat
Sept 4 (Reuters) - STOCKS NEWS Reuters Results diary Stocks on the move [HOT-RTRS] Real-time Equity News [E] [WEU/EQUITY] 07:48GM[4 Sep '08]
CORRECTED-STOCKS NEWS EUROPE-UK small caps fall 0.2%
Sept 4 (Reuters) - (Corrects comparison to show pan-European small caps underperformed the large caps) STOCKS NEWS Reuters Results dia[4 Sep '08]
UPDATE 1-SkyePharma sets new terms for convertibles
LONDON, Sept 1 (Reuters) - Specialist British drug delivery company SkyePharma Plc[1 Sep '08]
BRIEF-SkyePharma in 18.4 mln stg placing and open offer
LONDON, Sept 1 (Reuters) - SkyePharma Plc[1 Sep '08]
SkyePharma bond renegotiation deal seen 'this week'
LONDON, Sept 1 (Reuters) - Specialist drug delivery company SkyePharma Plc is set to announce a renegotiation of its convertible bonds this week[1 Sep '08]
